Adverse effect · Epitalon

How common is safety in humans with Epitalon?

D
Grade D — no human evidenceNone systematic · effect size: not measurable · adverse
Short answerNo human evidence. As of 2 September 2026, only none systematic exist for Epitalon for safety in humans. No adverse-event data collected to modern standards. Unknown is not the same as safe.

What the studies show

No adverse-event data collected to modern standards. Unknown is not the same as safe.

Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.

In context

Epitalon is a synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) developed in St Petersburg in the 1980s and promoted for longevity on the basis of telomerase activation in cell culture and lifespan effects in mice. The human evidence comes from one research group, is uncontrolled, and much of it used Epithalamin — a pineal-gland extract — rather than the synthetic peptide sold under the name. It is not approved anywhere.

Epitalon is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Epitalon proven to cause safety in humans?
No. There is no human evidence for it (None systematic); the claim rests on animal or cell studies and LYO grades it D.
What studies are behind the grade?
No adverse-event data collected to modern standards. Unknown is not the same as safe.
Is Epitalon approved for this?
No. Epitalon is not approved; it is not an approved medicine for any indication in the jurisdictions LYO covers.

Other outcomes for Epitalon

Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →